Logo image of PRKS

UNITED PARKS & RESORTS INC (PRKS) Stock Fundamental Analysis

NYSE:PRKS - New York Stock Exchange, Inc. - US81282V1008 - Common Stock - Currency: USD

48.46  +1.31 (+2.78%)

After market: 48.46 0 (0%)

Fundamental Rating

5

We assign a fundamental rating of 5 out of 10 to PRKS. PRKS was compared to 133 industry peers in the Hotels, Restaurants & Leisure industry. PRKS has a medium profitability rating, but doesn't score so well on its financial health evaluation. PRKS is valued quite cheap, while showing a decent growth score. This is a good combination!


Dividend Valuation Growth Profitability Health

6

1. Profitability

1.1 Basic Checks

PRKS had positive earnings in the past year.
In the past year PRKS had a positive cash flow from operations.
PRKS had positive earnings in 4 of the past 5 years.
PRKS had a positive operating cash flow in 4 of the past 5 years.
PRKS Yearly Net Income VS EBIT VS OCF VS FCFPRKS Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2020 2021 2022 2023 2024 0 200M -200M 400M

1.2 Ratios

PRKS's Return On Assets of 8.66% is amongst the best of the industry. PRKS outperforms 82.71% of its industry peers.
With an excellent Return On Invested Capital value of 16.40%, PRKS belongs to the best of the industry, outperforming 85.71% of the companies in the same industry.
Measured over the past 3 years, the Average Return On Invested Capital for PRKS is above the industry average of 13.81%.
Industry RankSector Rank
ROA 8.66%
ROE N/A
ROIC 16.4%
ROA(3y)10.09%
ROA(5y)5.59%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)17.51%
ROIC(5y)N/A
PRKS Yearly ROA, ROE, ROICPRKS Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2020 2021 2022 2023 2024 0 200 -200 -400 -600

1.3 Margins

Looking at the Profit Margin, with a value of 12.98%, PRKS belongs to the top of the industry, outperforming 83.46% of the companies in the same industry.
PRKS's Profit Margin has declined in the last couple of years.
With an excellent Operating Margin value of 26.73%, PRKS belongs to the best of the industry, outperforming 94.74% of the companies in the same industry.
In the last couple of years the Operating Margin of PRKS has declined.
PRKS has a Gross Margin of 48.83%. This is comparable to the rest of the industry: PRKS outperforms 52.63% of its industry peers.
In the last couple of years the Gross Margin of PRKS has remained more or less at the same level.
Industry RankSector Rank
OM 26.73%
PM (TTM) 12.98%
GM 48.83%
OM growth 3Y-2.3%
OM growth 5YN/A
PM growth 3Y-8.23%
PM growth 5YN/A
GM growth 3Y-1.41%
GM growth 5YN/A
PRKS Yearly Profit, Operating, Gross MarginsPRKS Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2020 2021 2022 2023 2024 0 20 -20 40 -40 -60

3

2. Health

2.1 Basic Checks

The Return on Invested Capital (ROIC) is well above the Cost of Capital (WACC), so PRKS is creating value.
Compared to 1 year ago, PRKS has less shares outstanding
PRKS has a worse debt/assets ratio than last year.
PRKS Yearly Shares OutstandingPRKS Yearly Shares OutstandingYearly Shares Outstanding 2020 2021 2022 2023 2024 20M 40M 60M
PRKS Yearly Total Debt VS Total AssetsPRKS Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2020 2021 2022 2023 2024 500M 1B 1.5B 2B 2.5B

2.2 Solvency

An Altman-Z score of 2.02 indicates that PRKS is not a great score, but indicates only limited risk for bankruptcy at the moment.
Looking at the Altman-Z score, with a value of 2.02, PRKS is in line with its industry, outperforming 59.40% of the companies in the same industry.
The Debt to FCF ratio of PRKS is 10.36, which is on the high side as it means it would take PRKS, 10.36 years of fcf income to pay off all of its debts.
With a decent Debt to FCF ratio value of 10.36, PRKS is doing good in the industry, outperforming 60.90% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF 10.36
Altman-Z 2.02
ROIC/WACC2.13
WACC7.71%
PRKS Yearly LT Debt VS Equity VS FCFPRKS Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2020 2021 2022 2023 2024 0 500M 1B 1.5B 2B

2.3 Liquidity

PRKS has a Current Ratio of 0.59. This is a bad value and indicates that PRKS is not financially healthy enough and could expect problems in meeting its short term obligations.
PRKS's Current ratio of 0.59 is on the low side compared to the rest of the industry. PRKS is outperformed by 70.68% of its industry peers.
PRKS has a Quick Ratio of 0.59. This is a bad value and indicates that PRKS is not financially healthy enough and could expect problems in meeting its short term obligations.
PRKS has a Quick ratio of 0.47. This is in the lower half of the industry: PRKS underperforms 72.18% of its industry peers.
Industry RankSector Rank
Current Ratio 0.59
Quick Ratio 0.47
PRKS Yearly Current Assets VS Current LiabilitesPRKS Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2020 2021 2022 2023 2024 100M 200M 300M 400M 500M

4

3. Growth

3.1 Past

PRKS shows a small growth in Earnings Per Share. In the last year, the EPS has grown by 0.81%.
Measured over the past years, PRKS shows a very strong growth in Earnings Per Share. The EPS has been growing by 27.25% on average per year.
The Revenue has decreased by -0.92% in the past year.
The Revenue has been growing slightly by 4.69% on average over the past years.
EPS 1Y (TTM)0.81%
EPS 3Y6.32%
EPS 5Y27.25%
EPS Q2Q%-70.59%
Revenue 1Y (TTM)-0.92%
Revenue growth 3Y4.69%
Revenue growth 5YN/A
Sales Q2Q%-3.52%

3.2 Future

Based on estimates for the next years, PRKS will show a quite strong growth in Earnings Per Share. The EPS will grow by 13.87% on average per year.
Based on estimates for the next years, PRKS will show a small growth in Revenue. The Revenue will grow by 2.19% on average per year.
EPS Next Y21.32%
EPS Next 2Y14.18%
EPS Next 3Y13.87%
EPS Next 5YN/A
Revenue Next Year0.74%
Revenue Next 2Y1.53%
Revenue Next 3Y2.19%
Revenue Next 5YN/A

3.3 Evolution

The estimated forward EPS growth is still strong, although it is decreasing when compared to the stronger growth in the past years.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
PRKS Yearly Revenue VS EstimatesPRKS Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 500M 1B 1.5B
PRKS Yearly EPS VS EstimatesPRKS Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 0 2 -2 4 -4

8

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings ratio is 12.92, which indicates a correct valuation of PRKS.
87.97% of the companies in the same industry are more expensive than PRKS, based on the Price/Earnings ratio.
PRKS is valuated cheaply when we compare the Price/Earnings ratio to 27.21, which is the current average of the S&P500 Index.
With a Price/Forward Earnings ratio of 9.61, the valuation of PRKS can be described as very reasonable.
88.72% of the companies in the same industry are more expensive than PRKS, based on the Price/Forward Earnings ratio.
Compared to an average S&P500 Price/Forward Earnings ratio of 21.70, PRKS is valued rather cheaply.
Industry RankSector Rank
PE 12.92
Fwd PE 9.61
PRKS Price Earnings VS Forward Price EarningsPRKS Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 20 40 60

4.2 Price Multiples

PRKS's Enterprise Value to EBITDA ratio is rather cheap when compared to the industry. PRKS is cheaper than 83.46% of the companies in the same industry.
87.97% of the companies in the same industry are more expensive than PRKS, based on the Price/Free Cash Flow ratio.
Industry RankSector Rank
P/FCF 12.31
EV/EBITDA 7.62
PRKS Per share dataPRKS EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 10 -10 20 30

4.3 Compensation for Growth

The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
The decent profitability rating of PRKS may justify a higher PE ratio.
PRKS's earnings are expected to grow with 13.87% in the coming years. This may justify a more expensive valuation.
PEG (NY)0.61
PEG (5Y)0.47
EPS Next 2Y14.18%
EPS Next 3Y13.87%

0

5. Dividend

5.1 Amount

PRKS does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

UNITED PARKS & RESORTS INC

NYSE:PRKS (7/1/2025, 7:34:19 PM)

After market: 48.46 0 (0%)

48.46

+1.31 (+2.78%)

Chartmill FA Rating
GICS SectorConsumer Discretionary
GICS IndustryGroupConsumer Services
GICS IndustryHotels, Restaurants & Leisure
Earnings (Last)05-12 2025-05-12/bmo
Earnings (Next)08-05 2025-08-05/bmo
Inst Owners76.19%
Inst Owner ChangeN/A
Ins Owners1.65%
Ins Owner Change3.31%
Market Cap2.66B
Analysts73.68
Price Target58.51 (20.74%)
Short Float %23.37%
Short Ratio8.12
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-24%
Min EPS beat(2)-25.66%
Max EPS beat(2)-22.35%
EPS beat(4)0
Avg EPS beat(4)-15.72%
Min EPS beat(4)-25.66%
Max EPS beat(4)-6.9%
EPS beat(8)1
Avg EPS beat(8)-9.34%
EPS beat(12)3
Avg EPS beat(12)-10.97%
EPS beat(16)6
Avg EPS beat(16)37.4%
Revenue beat(2)0
Avg Revenue beat(2)-2.74%
Min Revenue beat(2)-4.32%
Max Revenue beat(2)-1.16%
Revenue beat(4)0
Avg Revenue beat(4)-2.86%
Min Revenue beat(4)-4.32%
Max Revenue beat(4)-1.16%
Revenue beat(8)1
Avg Revenue beat(8)-2.71%
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0.8%
PT rev (3m)-10.99%
EPS NQ rev (1m)-0.46%
EPS NQ rev (3m)-1.45%
EPS NY rev (1m)0.53%
EPS NY rev (3m)0.97%
Revenue NQ rev (1m)0.02%
Revenue NQ rev (3m)-0.37%
Revenue NY rev (1m)-0.11%
Revenue NY rev (3m)-0.79%
Valuation
Industry RankSector Rank
PE 12.92
Fwd PE 9.61
P/S 1.55
P/FCF 12.31
P/OCF 6.13
P/B N/A
P/tB N/A
EV/EBITDA 7.62
EPS(TTM)3.75
EY7.74%
EPS(NY)5.05
Fwd EY10.41%
FCF(TTM)3.94
FCFY8.12%
OCF(TTM)7.9
OCFY16.31%
SpS31.2
BVpS-8.7
TBVpS-12.78
PEG (NY)0.61
PEG (5Y)0.47
Profitability
Industry RankSector Rank
ROA 8.66%
ROE N/A
ROCE 21.46%
ROIC 16.4%
ROICexc 17%
ROICexgc 19.07%
OM 26.73%
PM (TTM) 12.98%
GM 48.83%
FCFM 12.62%
ROA(3y)10.09%
ROA(5y)5.59%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)17.51%
ROIC(5y)N/A
ROICexc(3y)18.78%
ROICexc(5y)N/A
ROICexgc(3y)21.23%
ROICexgc(5y)N/A
ROCE(3y)22.92%
ROCE(5y)N/A
ROICexcg growth 3Y-2.62%
ROICexcg growth 5YN/A
ROICexc growth 3Y-2.07%
ROICexc growth 5YN/A
OM growth 3Y-2.3%
OM growth 5YN/A
PM growth 3Y-8.23%
PM growth 5YN/A
GM growth 3Y-1.41%
GM growth 5YN/A
F-Score5
Asset Turnover0.67
Health
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF 10.36
Debt/EBITDA 3.57
Cap/Depr 131.39%
Cap/Sales 12.72%
Interest Coverage 250
Cash Conversion 69.59%
Profit Quality 97.21%
Current Ratio 0.59
Quick Ratio 0.47
Altman-Z 2.02
F-Score5
WACC7.71%
ROIC/WACC2.13
Cap/Depr(3y)160.4%
Cap/Depr(5y)128.08%
Cap/Sales(3y)14.55%
Cap/Sales(5y)15.5%
Profit Quality(3y)104.08%
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)0.81%
EPS 3Y6.32%
EPS 5Y27.25%
EPS Q2Q%-70.59%
EPS Next Y21.32%
EPS Next 2Y14.18%
EPS Next 3Y13.87%
EPS Next 5YN/A
Revenue 1Y (TTM)-0.92%
Revenue growth 3Y4.69%
Revenue growth 5YN/A
Sales Q2Q%-3.52%
Revenue Next Year0.74%
Revenue Next 2Y1.53%
Revenue Next 3Y2.19%
Revenue Next 5YN/A
EBIT growth 1Y-2.74%
EBIT growth 3Y2.28%
EBIT growth 5YN/A
EBIT Next Year43.82%
EBIT Next 3Y16.2%
EBIT Next 5YN/A
FCF growth 1Y15.81%
FCF growth 3Y-14.76%
FCF growth 5YN/A
OCF growth 1Y-4.91%
OCF growth 3Y-1.54%
OCF growth 5YN/A